These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9569418)

  • 1. Preventing RhD haemolytic disease of the newborn. Women should be counselled about source of anti-D immunoglobulin.
    Saha A
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569418
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C; Wray J
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S; O'riordan JM; Lawlor E; Murphy WG
    Vox Sang; 2005 Jul; 89(1):49-51. PubMed ID: 15938740
    [No Abstract]   [Full Text] [Related]  

  • 6. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D. Part 2: Risks and benefits.
    Wickham S
    Pract Midwife; 1999 Jun; 2(6):38-9. PubMed ID: 10481677
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
    Chauhan AR; Bhattacharyya MS; Turakhia N; Daftary GV
    J Assoc Physicians India; 2002 Oct; 50():1341-2. PubMed ID: 12568238
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 12. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
    Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
    Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-D administration after childbirth for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 May; 2(5):10-1. PubMed ID: 12024602
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 17. RhD negative women. Are we ready to change practice?
    Wray J
    Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
    [No Abstract]   [Full Text] [Related]  

  • 18. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing RhD haemolytic disease of the newborn. RhD negative women who have intrauterine death may need anti-D immunoglobulin.
    Fox R
    BMJ; 1998 Apr; 316(7138):1164-5. PubMed ID: 9569416
    [No Abstract]   [Full Text] [Related]  

  • 20. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.